Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Minnuo Biotechnology
Beijing, Beijing, Chinaminnuobio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is currently conducting Phase 1 and Phase 2 clinical trials for its lead CAR-T programs, showing promising safety and efficacy profiles in refractory or relapsed multiple myeloma and B-cell malignancies, particularly through its proprietary umbilical cord blood-mediated CAR-T technology.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyCAR-T cell therapyBiologic
- Industry
- Biotech
02
Partnerships
Seventh Medical Center of PLA General HospitalShaanxi People's Hospital
Beyond the preview
Go deeper on Beijing Minnuo Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Minnuo Biotechnology.